임상시험 트래커

추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov

20건 표시

2상모집 예정· Advanced or Metastatic Solid Tumour
SCALp Cooling for pReventing aLopecia With nEw anTibody-drug Conjugates
협력: 길리어드
상세 →NCT07474558
3상모집 예정· HIV Infection
Duo: A Phase IIIb Individual-Level Randomized Controlled Trial of an Integrated Strategy
협력: 길리어드
상세 →NCT07658976
4상모집 예정· HIV - Human Immunodeficiency Virus
Combating Related Epidemics in HCV
협력: 길리어드
상세 →NCT07560046
1상모집 예정· Solid Tumor
A Study to Evaluate the Safety and Antitumor Activity of GS-1206 in Adults With Solid Tumors
리드: 길리어드
상세 →NCT07703878
해당없음모집 예정· HIV Prevention
Leveraging Chatbot to Improve PrEP in the Southern United States
협력: 길리어드
상세 →NCT05968755
3상모집 예정· HIV-1-infection
Study of Lenacapavir, Teropavimab, and Zinlirvimab in Virologically Suppressed Adults With HIV-1 on Stable Oral Treatment Regimens
리드: 길리어드
상세 →NCT07683000
3상모집 예정· Talaromycosis
Liposomal Amphotericin B and Flucytosine Antifungal Strategy for Talaromycosis (LAmB-FAST)
협력: 길리어드
상세 →NCT06525389
3상모집 예정· HIV Infections
Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy
리드: 길리어드
상세 →NCT07682961
2/3상모집 예정· HIV-1-infection
Study of an Injectable Regimen of GS-3242 With Lenacapavir Compared to Biktarvy in People New to HIV-1 Treatment
리드: 길리어드
상세 →NCT07708727
3상모집 예정· Breast Cancer
NeoAdjuvant Therapy Comparing Sacituzumab Govitecan+Pembrolizumab vs. SoC Chemotherapy in Clinical Stage II-III, Triple-negative Early Breast Cancer
협력: 길리어드
상세 →NCT07178730
해당없음모집 예정· HIV
HIV/HBV/HCV Triple Screening in Primary Care
협력: 길리어드
상세 →NCT07031219
1상모집 예정· Chronic Pulmonary Aspergillosis
Deposition of Inhaled Liposomal Amphotericin B in Chronic Pulmonary Aspergillosis (CPA)
협력: 길리어드
상세 →NCT07530263
단계 미표기모집 예정· People Who Inject Drugs
CARE: Comprehensive Assessment of Real-world Effectiveness of F/TAF in Persons Who Use Drugs (PWUD)
협력: 길리어드
상세 →NCT07385183
단계 미표기모집 예정· HIV
ALIGN: A Non-randomised Study Delivering Injectable Lenacapavir for HIV Prevention Within a Pre-exposure Prophylaxis (PrEP) Choice Context in Cape Town, South Africa.
협력: 길리어드
상세 →NCT07390409
단계 미표기모집 예정· HIV Pre-exposure Prophylaxis
Long-Acting Injectable HIV PrEP PROs
협력: 길리어드
상세 →NCT07379658
1상모집 예정· Stage IV (Metastatic) Breast Cancer
A Trial to Evaluate Sacituzumab Govitecan in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Metastatic Breast Cancer Progressed on CDK4/6 Inhibitors
협력: 길리어드
상세 →NCT07163481
해당없음모집 예정· HIV-1-infection
A Study to Determine the Cartography of Virologic Reservoir Related to Antiretroviral Concentrations in HIV-1 Chronic Patients Treated by a First Line Treatment Containing bictégravir, Emtricitabine and ténofovir alafénamide
협력: 길리어드
상세 →NCT05222945
4상모집 예정· HIV Infection
Same-Day Restart of B/F/TAF in HIV Patients After NNRTI Discontinuation
협력: 길리어드
상세 →NCT06830668
단계 미표기모집 예정· Hepatitis D Virus Infection
MIGrant Reflex Test HDV (MIGRED) Project
협력: 길리어드
상세 →NCT06539052
2상모집 예정· Bladder Cancer
Bladder Preservation With Sacituzumab Govitecan + Zimberelimab for Muscle-Invasive Bladder Cancer
협력: 길리어드
상세 →NCT06528483

BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.